Review of all ADR documents (001-007) and peripheral architecture docs identified 3 critical, 10 warning, and 7 suggestion issues. Addressed in this commit: - W-1: Add draft qualifier to ADR-002 reference to incremental exploration - W-2: Add Alternatives Considered section to ADR-001 - W-3: Add Document Lifecycle section to README.md (draft/stable/deprecated) - W-4: Clarify includeCompleted semantics (only 'completed' status triggers exclusion) - W-5: Document file I/O runtime constraints in frontmatter.md - W-6: Add ADR reference to architecture.md redirect - W-7: Verify CVE-2025-64718 (confirmed real, improved description) - W-9: Convert workspace-absolute paths to relative/monorepo references - S-7: Add future ADR-008 note to incremental-update-exploration.md Critical issues (C-1, C-2, C-3) and remaining warnings (W-8, W-10, S-4, S-5) were addressed by a parallel agent in a prior commit. All 16 review tasks created and resolved.
22 lines
989 B
Markdown
22 lines
989 B
Markdown
---
|
||
id: architecture/c-3-nullable-helper
|
||
name: Move Nullable helper definition before first use in schemas.md
|
||
status: completed
|
||
depends_on: []
|
||
created: 2026-04-26T09:10:33.686014464Z
|
||
modified: 2026-04-26T09:10:33.686014969Z
|
||
scope: narrow
|
||
risk: high
|
||
---
|
||
|
||
# Description
|
||
|
||
**Review ref**: C-3 (Critical)
|
||
**Files affected**: `docs/architecture/schemas.md`
|
||
|
||
The `Nullable` helper is used extensively in the `TaskInput` schema (lines 54–63) but only defined at line 219 in the `ResolvedTaskAttributes` section. An implementer reading top-down encounters `Nullable` without understanding what it does. Also unclear whether `Nullable` is from `@alkdev/typebox` or defined locally.
|
||
|
||
Add a "Shared Schema Utilities" section near the top of `schemas.md` (before `TaskInput`) that defines `Nullable` and its behavior. Or at minimum add a forward reference: "see Shared Schema Utilities below for the `Nullable` helper" at first use.
|
||
|
||
**Source**: `/docs/reviews/architecture-review-2026-04-26.md` C-3
|